ASCO: PARP Inhibitor Slows Recurrent Ovarian Cancer - QualityPoint Technologies
Links shared publicly online about this topic.
- 283total visits
ASCO: PARP Inhibitor Slows Recurrent Ovarian Cancer - QualityPoint Technologies
CHICAGO (MedPage Today) -- Treatment with an investigational DNA repair inhibitor almost doubled progression-free survival in patients with relapsed, platinum-sensitive ovarian cancer, data from a randomized trial showed.
View full resource at qualitypointtech.net
Tags: Cancer, Ovarian Cancer, Women's Health
Most Recently Shared on May 18, 2011 at 11:45 pm By:
ASCO: PARP Inhibitor Slows Recurrent Ovarian Cancer: CHICAGO (MedPage Today) -- Treatment with an investigational ... http://bit.ly/kWiXXK
Medical News: ASCO: PARP Inhibitor Slows Recurrent Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Treatment with an investigational DNA repair inhibitor almost doubled progression-free survival in patients with relapsed, platinum-sensitive ovarian cancer, data from a randomized trial sh” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 7:28 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Medical News: ASCO: PARP Inhibitor Slows Recurrent Ovarian Cancer - http://t.co/VTLxRs4 from @medpagetoday #health #medicine
Advertisement
